After just 50 days on the job, Tatung Co (大同) chairman Lin Wen-yuan (林文淵) has been dismissed.
Lin made the announcement at a news conference in Taipei yesterday, saying that he “does not know exactly why myself” the reason for his tenure being cut short.
Lin said that he had “minor differences of opinion” with Tatung’s leading investor, Shanyuan Group (三圓建設) chairman Wang Kuang-hsiang (王光祥), who informed Lin on Monday last week that he would be replaced.
Photo: Tu Chien-jung, Taipei Times
“I asked him why. What did I do wrong? He said: ‘Nothing, but it’s now a different time with different circumstances,’” said Lin, describing a conversation with Wang.
When asked to name a point of friction with Wang, Lin said that Wang wants to be Tatung vice chairman.
“He mentioned it at the very first board meeting. I told him it was on the table, but we have to amend some company by-laws first,” Lin said.
“As the largest shareholder, Wang thought his suggestion should be accepted, but there are possible legal ramifications,” he said.
Lin said that he did not know who would take over at Tatung, but an announcement is scheduled for today.
His picks for Tatung president, Tang Cheng-jen (湯政仁) and chief financial officer Chen Ming-nan (陳明男), have already tendered their resignations.
The Chinese-language Mirror Media weekly reported that Lin’s choices for president were questioned by former Tatung chairwoman Lin Kuo Wen-yen (林郭文艷), who remains on the board, citing lack of experience.
Tang was an assistant professor of electrical engineering at Tatung University for 17 years before founding a start-up, SourceTec Co (思源資訊).
Lin Wen-yuan, who is also chairman of Eastern Broadcasting Co (東森電視), said that he had “given it my all” in his effort to turn around the beleaguered company after being made chairman on Nov. 2.
He was brought in by Wang after a group of activist investors led by Wang wrested control of the company away from Lin Kuo Wen-yen, the last representative of the founding Lin family at Tatung.
At a news conference last month announcing Lin Wen-yuan’s appointment as chairman, he and Wang promised that it would be “a new Tatung” and the end of years of boardroom drama.
However, the relationship between the two has been “irreparably ruptured” by arguing over Tatung’s management, reports have said.
“It is not as bad as that, but it might be difficult for us to work together in the future,” Lin Wen-yuan said.
UNCONVINCING: The US Congress questioned whether the company’s Chinese owners pose a national security risk and how the app might influence young users TikTok chief executive officer Shou Chew (周受資), confronted with an unforgiving, distrustful US Congress, tried to give answers in his testimony on Thursday that avoided offending either the US government or China. However, his evasiveness left Congress unsatisfied, with representatives hungrier than ever to punish TikTok for ties to its parent company ByteDance Ltd (字節跳動), based in Beijing. He did not bring his company any closer to a resolution. Politically, TikTok is in a tougher spot. Its executives had been discussing divesting from ByteDance to resolve US national security concerns, people familiar with the matter told Bloomberg. However, China this week said
Microsoft Corp has threatened to cut off access to its Internet search data, which it licenses to rival search engines, if they do not stop using it as the basis for their own artificial intelligence (AI) chat products, people familiar with the dispute have said. The software maker licenses the data in its Bing search index — a map of the Internet that can be quickly scanned in real time — to other companies that offer Web search, such as Apollo Global Management Inc’s Yahoo and DuckDuckGo. Last month, Microsoft integrated a cousin of ChatGPT, OpenAI’s AI-powered chat technology, into Bing. Rivals
Sanofi SA’s drug Dupixent succeeded in a late-stage trial for chronic obstructive pulmonary disease (COPD), raising the odds that the blockbuster would be the first biologic medicine cleared to treat the lung disorder. Dupixent, which is already prescribed for asthma and some skin conditions, showed a 30 percent reduction in the rate at which patients’ COPD worsened compared with those who received a placebo during the stage-three Boreas trial, the company said in a statement yesterday. The positive data could herald a new era of cutting-edge treatments for the life-threatening respiratory affliction and provide another major boost in demand for the French
SEMICONDUCTOR EQUIPMENT: The international trade group said the sector would recover from a slump, with spending expected to rise 4.2 percent to US$24.9 billion Taiwan is to retain its position as the top spender on semiconductor front-end equipment and facilities next year, with spending expected to increase 4.2 percent year-on-year to US$24.9 billion, international trade group SEMI said yesterday. The spending forecast matches an expected recovery in global semiconductor equipment and facilities investment next year, it said. International equipment spending is to return to growth next year, SEMI said in a report, forecasting 21 percent growth to US$92 billion. The expansion would manly be driven by robust demand for semiconductors in the automotive and high-performance computing segments, the association said. “This quarter’s SEMI World Fab Forecast update